For almost 20 years, hundreds of people in Northern Ireland haven't had to travel on a cancer journey alone thanks to Joanne Boal. The Belfast-based art therapist has worked for leading local ...

No one knows for certain why Feehan, who serves as an avionics technician, developed a rare brain cancer with an average ... trying to free him from the responsibility of caring for his family.

“I was at the start of my life, with so many dreams ahead of me. When I heard I had brain cancer, it felt like my world had stopped,” said Khaled. What followed was a gruelling battle ...

“Isabella Strahan was diagnosed with medulloblastoma, a common fast-growing malignant brain tumor ... recovery and recent return to college cancer-free. Isabella reflects on her fight and ...

The 60,850-square-foot hub will be a state-of-the-art cancer ... Many cancer patients are forced to travel far distances to participate in these trials. The American Cancer Society has a Hope Lodge in ...

setting an ambitious goal of making Maharashtra cancer-free through public participation. The initiative, inaugurated at Mumbai's Yashwantrao Chavan Auditorium, will focus on screening ...

Since the trial patients received the vaccine roughly three years ago, they have stayed cancer-free. The early results suggest that these vaccines may someday be able to tackle a wider variety of ...

The emotional experiences of cancer patients, from diagnosis to treatment and beyond, are being brought to life through artificial intelligence technology in a groundbreaking exhibition in Ankara. The ...

The Irish Cancer Society is expanding its supports to address what it says are the “unmet needs” of patients with the illness. The charity is unveiling new free services, which include a ...

Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 ...

A new targeted therapy, CT-179, shows promise in treating childhood brain cancers like medulloblastoma by effectively targeting cancer stem cells responsible for recurrence and therapy resistance.